Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TAF1D |
| Upstream (Parents) |
|---|
| (<<) F8 → TAF1D |
| (<<) FAM60A → TAF1D |
| (<<) MYC → TAF1D |
| Downstream (Children) |
|---|
| TAF1D → MAF (>>) |
| TAF1D → GFRA2 (>>) |
| TAF1D → FLJ41278///TBC1D30 (>>) |
| TAF1D → RPS2 (>>) |
| TAF1D → E2F5 (>>) |
| TAF1D → MYC (>>) |
| TAF1D → ZNF239 (>>) |
| TAF1D → GNA14 (>>) |
| TAF1D → PPFIA1 (>>) |
| TAF1D → NPM3 (>>) |
| TAF1D → CD3EAP (>>) |
| TAF1D → PUS7 (>>) |
